FIELD: chemistry.
SUBSTANCE: invention relates to a quinazoline derivative of general formula [1], or a pharmaceutically acceptable salt thereof [1], where R1-R6 assume values given claim 1, except compounds in which R5 is hydrogen and R6 is -NH2. The invention also relates to a pharmaceutical composition having the activity of an antipruritic agent, containing as an active ingredient said quinazoline derivative or pharmaceutically acceptable salt thereof.
EFFECT: obtaining a novel quinazoline derivative with low irritant action on skin and excellent action of significant suppression of scratching behaviour, as well as an antipruritic agent containing such a quinazoline derivative as an active ingredient.
9 cl, 250 ex, 7 tbl
Title | Year | Author | Number |
---|---|---|---|
QUINAZOLINE AND QUINOLINE DERIVATIVES AND MEDICINAL AGENTS BASED ON THEREOF | 2001 |
|
RU2268260C2 |
DIAMINE DERIVATIVES | 2003 |
|
RU2333203C2 |
NEW DERIVATIVES OF QUINUCLIDINE AND MEDICINAL COMPOSITIONS CONTAINING THEREOF | 1995 |
|
RU2143432C1 |
INDANOL DERIVATIVES | 2005 |
|
RU2323937C1 |
PEPTIDILE HETEROCYCLES USED TO TREAT THROMBIN- ASSOCIATED DISEASES | 1996 |
|
RU2181125C2 |
SULFONYLALKANOYLAMINO-HYDROXYETHYLAMINO-SULFONAMIDE COMPOUND, PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATMENT AND INHIBITION OF RETROVIRAL PROTEASES | 1993 |
|
RU2146668C1 |
ACYLATED HETEROALICYCLIC DERIVATIVES, MEDICINAL AGENT SHOWING SELECTIVE ANTAGONISTIC ACTIVITY AGAINST NK-RECEPTORS, METHOD OF PROPHYLAXIS OR TREATMENT OF PATIENTS | 1998 |
|
RU2174122C1 |
SUBSTITUTED N-(INDOLE-2-CARBONYL)-BETA-ALANYLAMIDES AND THEIR DERIVATIVES, METHOD OF TREATING GLYCOGENPHOSPHORYLAZO-DEPENDENT DISEASES, METHOD FOR PREVENTING ISCHEMIC MYOCARDIUM DAMAGES, AND PHARMACEUTICAL COMPOSITIONS | 1996 |
|
RU2159613C2 |
DERIVATIVES OF DIAZEPINE, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT OF PATIENTS WITH ARRYTHMIA | 1994 |
|
RU2155587C2 |
METHOD OF SYNTHESIS OF TETRAHYDROBENZIMIDAZOLE DERIVATIVE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT | 1990 |
|
RU2024516C1 |
Authors
Dates
2012-10-20—Published
2006-10-03—Filed